Old Web
English
Sign In
Acemap
>
authorDetail
>
Dirk Müller‐Wieland
Dirk Müller‐Wieland
Technische Hochschule
Endocrinology
Internal medicine
Diabetes mellitus
Medicine
Placebo
3
Papers
158
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes
2018
Diabetes, Obesity and Metabolism
Dirk Müller‐Wieland
Monika Kellerer
Katarzyna Cypryk
Dasa Skripova
K Rohwedder
Eva Johnsson
Ricardo Garcia-Sanchez
Raisa Kurlyandskaya
C. David Sjöström
Stephan Jacob
Jochen Seufert
Nalina Dronamraju
Katalin Csomós
Show All
Source
Cite
Save
Citations (32)
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial
2017
Diabetes & Metabolism
Bertrand Cariou
Lawrence A. Leiter
Dirk Müller‐Wieland
G. Bigot
Helen M. Colhoun
S. Del Prato
Robert R. Henry
Francisco J. Tinahones
Alexia Letierce
L. Aurand
Jaman Maroni
Kausik K. Ray
Maja Bujas-Bobanovic
Show All
Source
Cite
Save
Citations (14)
1